CureDM
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(610) 645-6796Website
www.curedm.comRevenue
<$5 MillionIndustry
About CureDM
Is CureDM your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CureDM has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CureDM launches new products
Check if CureDM has recently received funding, and reach out quickly before it becomes old news!
Check out if CureDM is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CureDM recently announced quarterly report
CureDM, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CureDM
Click to see if CureDM had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at CureDM
Find 2 more new buyers
Compare Similar Companies to CureDM
Compare insights from companies similar to CureDM, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CureDM
Company Profile Activity
Activity Insights
CureDM is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CureDM is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CureDM.
CureDM Tech Stack
A closer look at the technologies used by CureDM
CureDM News & Media
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CureDM
CureDM, Inc. is a biopharmaceutical company focused on developing new therapies to prevent, ameliorate, or reverse diabetes, potentially allowing for the discontinuation of insulin. The company has discovered a novel human peptide, HIP2B, which stimulates the regeneration of insulin-producing islets in the pancreas. CureDM aims to license or partne... Read More